There are 11 participating organisations in the study making up the study consortium . Each consortium member brings together African, European, and American researchers, under African leadership, to generate an innovative solution to one of the most pressing African problems - Drug-resistant TB (DR-TB). Each consortium member brings a unique set of skills and strengths to the partnership, resulting in a mutual collaboration that is highly supportive and invested in African research priorities and science generation that benefits the local population. Day-to-day management of the study and overview of study operations will be conducted by the lead organization, CAPRISA.

Study Teams